Publicaciones en colaboración con investigadores/as de Centro Nacional de Microbiología (32)

2026

  1. Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance

    Journal of Infection and Public Health, Vol. 19, Núm. 3

  2. Comparison of routine clinical profiles of patients with imported P. falciparum malaria and co-infection with Plasmodium ovale wallikeri or Plasmodium ovale curtisi

    Acta Tropica, Vol. 274

  3. Corrigendum to “Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance” [J Infect Public Health 19 (3) (2026) 103108]

    Journal of Infection and Public Health

  4. Corrigendum to “Beyond COVID-19 in people with HIV: Specific miRNA expression profile persist after SARS-CoV-2 clearance” [J Infect Public Health 19 (3) (2026) 103108] (Journal of Infection and Public Health (2026) 19(3), (S1876034125004575), (10.1016/j.jiph.2025.103108))

    Journal of Infection and Public Health

  5. Diagnosis of HIV infection during pregnancy: Trends from a national cohort in Spain

    HIV Medicine, Vol. 27, Núm. 2, pp. 270-282

  6. One-year consolidation with Ponatinib 15 mg in chronic myeloid leukaemia on deep molecular response with Imatinib

    Annals of Hematology, Vol. 105, Núm. 2

2025

  1. Correction: Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis (Frontiers in Immunology, (2025), 16, (1571680), 10.3389/fimmu.2025.1571680)

    Frontiers in Immunology

  2. Epidemiology and Risk Factors for HCV Infection Among MSM With or at Risk of HIV in Madrid (2022–2024)

    Open Forum Infectious Diseases, Vol. 12, Núm. 12

  3. Exploring the complexities of intestinal and pulmonary microbiota in cystic fibrosis: A multi-omics approach

    Respiratory Medicine, Vol. 248

  4. Immune response dynamics of SARS-CoV-2 vaccination in chronic lymphocytic leukemia individuals: a descriptive analysis

    Frontiers in Immunology, Vol. 16

  5. Impact of the initial administration of an antiretroviral drug with latency reversal properties on the HIV reservoir size

    Scientific reports, Vol. 15, Núm. 1, pp. 25306

  6. Metabolic Complications After Initiating BIC/FTC/TAF Versus DTG + 3TC in Antiretroviral-therapy-naive Adults With HIV: A Multicenter Prospective Cohort Study

    Clinical Infectious Diseases, Vol. 81, Núm. 2, pp. 263-270

  7. Metabolomic Changes Associated With the Change in HVPG After DAAs Therapy in HCV Cirrhotic Patients

    Liver International, Vol. 45, Núm. 1

2024

  1. A Phase I/IIa Prospective, Randomized, Open-Label Study on the Safety and Efficacy of Nebulized Liposomal Amphotericin for Invasive Pulmonary Aspergillosis

    Journal of Fungi, Vol. 10, Núm. 3

  2. Correction to: High concentrations of Maraviroc do not alter immunological and metabolic parameters of CD4 T cells (Scientific Reports, (2024), 14, 1, (13980), 10.1038/s41598-024-64902-y)

    Scientific Reports

  3. High concentrations of Maraviroc do not alter immunological and metabolic parameters of CD4 T cells

    Scientific Reports, Vol. 14, Núm. 1

  4. Mitochondrial Haplogroups and Weight Gain After Initiating ART in Patients With HIV

    The Journal of infectious diseases, Vol. 230, Núm. 2, pp. 421-425

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

  2. Breakthrough invasive fungal infection among patients with haematologic malignancies: A national, prospective, and multicentre study

    Journal of Infection, Vol. 87, Núm. 1, pp. 46-53

  3. IRF5-TNOP3 polymorphisms are associated with elite control of HIV infection: A retrospective study

    Journal of medical virology, Vol. 95, Núm. 6, pp. e28841